116 related articles for article (PubMed ID: 1586340)
1. Human menopausal gonadotrophins in the treatment of unexplained infertility.
Hughes GJ; Garrett DK; Lowy M
Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):64-6. PubMed ID: 1586340
[TBL] [Abstract][Full Text] [Related]
2. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
Aboulghar MA; Mansour RT; Serour GI
Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
[TBL] [Abstract][Full Text] [Related]
4. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
Messinis IE; Bergh T; Wide L
Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrhoea using gonadotrophin releasing hormone analogue and human menopausal gonadotrophin.
Aboulghar MA; Mansour RT; Serour GI; Ramzy AM
Hum Reprod; 1990 Jul; 5(5):557-60. PubMed ID: 2118543
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility.
Sengoku K; Tamate K; Takaoka Y; Morishita N; Ishikawa M
Hum Reprod; 1994 Jun; 9(6):1043-7. PubMed ID: 7962373
[TBL] [Abstract][Full Text] [Related]
9. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient.
Blumenfeld Z; Lunenfeld B
Fertil Steril; 1989 Aug; 52(2):328-31. PubMed ID: 2502442
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the pregnancy and complication rates with human menopausal gonadotrophin therapy.
Ellis JD; Williamson JG
Br J Obstet Gynaecol; 1975 Jan; 82(1):52-7. PubMed ID: 1138820
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy.
Ben-Rafael Z; Mashiach S; Oelsner G; Farine D; Lunenfeld B; Serr DM
Fertil Steril; 1981 Nov; 36(5):560-4. PubMed ID: 6796437
[TBL] [Abstract][Full Text] [Related]
12. Results of treatments of infertile women with defective luteal phases by human menopausal gonadotrophin and human chorionic gonadotrophin.
Cooke ID
J Reprod Fertil; 1973 May; 33(2):355. PubMed ID: 4707338
[No Abstract] [Full Text] [Related]
13. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 2 methods for monitoring gonadotrophin therapy.
Sallam HN; Bashmi YA
Aust N Z J Obstet Gynaecol; 1989 May; 29(2):160-4. PubMed ID: 2508610
[TBL] [Abstract][Full Text] [Related]
15. Male to female ratio after gonadotropin-induced ovulation.
Ben-Rafael Z; Matalon A; Blankstein J; Serr DM; Lunenfeld B; Mashiach S
Fertil Steril; 1986 Jan; 45(1):36-40. PubMed ID: 3080345
[TBL] [Abstract][Full Text] [Related]
16. The value of human menopausal gonadotropin treatment in patients with unexplained infertility.
Gürgan T; Kişnişçi H; Yarali H; Aksu T; Zeyneloğlu H; Develioğlu O
Int J Gynaecol Obstet; 1991 Aug; 35(4):327-30. PubMed ID: 1682180
[TBL] [Abstract][Full Text] [Related]
17. Induction of ovulation with gonadotrophins--a ten year review.
West CP; Baird DT
Scott Med J; 1984 Oct; 29(4):212-7. PubMed ID: 6442464
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of sterility with human gonadotropins. (HMG-HCG)].
Montanino G; Coghi I; Carenza L
Patol Clin Ostet Ginecol; 1973; 1(3):108-17. PubMed ID: 4806755
[No Abstract] [Full Text] [Related]
19. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
20. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
Kamada S; Kubota T; Aso T
Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
